Prevalence of chronic kidney disease in an urban HIV infected population

Sanjay K Fernando1, Fredric O Finkelstein, Brent A Moore

  • 1Section of Nephrology, Department of Medicine, Hospital of Saint Raphael, New Haven, Connecticut, USA.

Insights

A significant number of HIV patients have chronic kidney disease (CKD), often undiagnosed. Hypertension and African American race are key risk factors for CKD in this population.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Public Health

Background:

  • The prevalence of chronic kidney disease (CKD) in HIV-infected individuals during the highly active antiretroviral therapy (HAART) era requires thorough evaluation.
  • Understanding CKD burden is crucial for managing long-term health outcomes in the growing HIV-positive population.

Purpose of the Study:

  • To determine the prevalence of CKD among HIV-infected patients.
  • To identify risk factors associated with CKD in this population.
  • To assess the clinical recognition of CKD in HIV-infected patients.

Main Methods:

  • Retrospective chart review of HIV-infected patients from 2004.
  • Utilized National Kidney Foundation's CKD staging criteria and Modification of Diet in Renal Disease (MDRD) formula for Glomerular Filtration Rate (GFR) calculation.
  • Performed univariate and multivariate analyses to identify CKD predictors.

Main Results:

  • CKD was found in 24% of HIV-infected patients, with varying stages.
  • African American race, older age, AIDS diagnosis, lower CD4 counts, higher HIV viral load, hypertension (HTN), and diabetes mellitus (DM) were associated with CKD.
  • Indinavir or tenofovir exposure was linked to CKD; HTN, AA race, or HTN and DM were significant predictors in multivariate analysis.
  • Physicians failed to identify CKD in 74% of cases; HIV-associated nephropathy was diagnosed in 50% of renal biopsies.

Conclusions:

  • A substantial proportion of HIV-infected patients have CKD, frequently unrecognized by clinicians.
  • Hypertension, African American race, and co-existing diabetes mellitus are significant risk factors for CKD in HIV-positive individuals.
  • Improved screening and clinical awareness are essential for managing CKD in the HIV population.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...